Aging-related Alzheimer's disease-like neuropathology and functional decline in captive vervet monkeys (Chlorocebus aethiops sabaeus). 2021

Brett M Frye, and Suzanne Craft, and Caitlin S Latimer, and C Dirk Keene, and Thomas J Montine, and Thomas C Register, and Miranda E Orr, and Kylie Kavanagh, and Shannon L Macauley, and Carol A Shively
Department of Pathology/Comparative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Age-related neurodegeneration characteristic of late-onset Alzheimer's disease (LOAD) begins in middle age, well before symptoms. Translational models to identify modifiable risk factors are needed to understand etiology and identify therapeutic targets. Here, we outline the evidence supporting the vervet monkey (Chlorocebus aethiops sabaeus) as a model of aging-related AD-like neuropathology and associated phenotypes including cognitive function, physical function, glucose handling, intestinal physiology, and CSF, blood, and neuroimaging biomarkers. This review provides the most comprehensive multisystem description of aging in vervets to date. This review synthesizes a large body of evidence that suggests that aging vervets exhibit a coordinated suite of traits consistent with early AD and provide a powerful, naturally occurring model for LOAD. Notably, relationships are identified between AD-like neuropathology and modifiable risk factors. Gaps in knowledge and key limitations are provided to shape future studies to illuminate mechanisms underlying divergent neurocognitive aging trajectories and to develop interventions that increase resilience to aging-associated chronic disease, particularly, LOAD.

UI MeSH Term Description Entries
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

Brett M Frye, and Suzanne Craft, and Caitlin S Latimer, and C Dirk Keene, and Thomas J Montine, and Thomas C Register, and Miranda E Orr, and Kylie Kavanagh, and Shannon L Macauley, and Carol A Shively
February 2014, Comparative medicine,
Brett M Frye, and Suzanne Craft, and Caitlin S Latimer, and C Dirk Keene, and Thomas J Montine, and Thomas C Register, and Miranda E Orr, and Kylie Kavanagh, and Shannon L Macauley, and Carol A Shively
December 1978, Behavioural processes,
Brett M Frye, and Suzanne Craft, and Caitlin S Latimer, and C Dirk Keene, and Thomas J Montine, and Thomas C Register, and Miranda E Orr, and Kylie Kavanagh, and Shannon L Macauley, and Carol A Shively
January 2022, Frontiers in veterinary science,
Brett M Frye, and Suzanne Craft, and Caitlin S Latimer, and C Dirk Keene, and Thomas J Montine, and Thomas C Register, and Miranda E Orr, and Kylie Kavanagh, and Shannon L Macauley, and Carol A Shively
December 2015, Genome research,
Brett M Frye, and Suzanne Craft, and Caitlin S Latimer, and C Dirk Keene, and Thomas J Montine, and Thomas C Register, and Miranda E Orr, and Kylie Kavanagh, and Shannon L Macauley, and Carol A Shively
October 2013, Comparative medicine,
Brett M Frye, and Suzanne Craft, and Caitlin S Latimer, and C Dirk Keene, and Thomas J Montine, and Thomas C Register, and Miranda E Orr, and Kylie Kavanagh, and Shannon L Macauley, and Carol A Shively
April 2018, Journal of medical primatology,
Brett M Frye, and Suzanne Craft, and Caitlin S Latimer, and C Dirk Keene, and Thomas J Montine, and Thomas C Register, and Miranda E Orr, and Kylie Kavanagh, and Shannon L Macauley, and Carol A Shively
June 2019, Journal of medical primatology,
Brett M Frye, and Suzanne Craft, and Caitlin S Latimer, and C Dirk Keene, and Thomas J Montine, and Thomas C Register, and Miranda E Orr, and Kylie Kavanagh, and Shannon L Macauley, and Carol A Shively
July 1979, Behavioural processes,
Brett M Frye, and Suzanne Craft, and Caitlin S Latimer, and C Dirk Keene, and Thomas J Montine, and Thomas C Register, and Miranda E Orr, and Kylie Kavanagh, and Shannon L Macauley, and Carol A Shively
October 2019, Metabolic brain disease,
Brett M Frye, and Suzanne Craft, and Caitlin S Latimer, and C Dirk Keene, and Thomas J Montine, and Thomas C Register, and Miranda E Orr, and Kylie Kavanagh, and Shannon L Macauley, and Carol A Shively
December 2013, Journal of medical primatology,
Copied contents to your clipboard!